Chemla A, Arena G, Onal G, Walter J, Berenguer Escuder C, Grossmann D, et al. Generation of two induced pluripotent stem cell lines and the corresponding isogenic controls from Parkinson's disease patients carrying the heterozygous mutations c.815G > A (p.R272Q) or c.1348C > T (p.R450C) in the RHOT1 g. Stem Cell Res. 2023;71:103145 pubmed publisher

Kim M, Park J, Kim S, Han D, Shin B, Sch xf6 ler H, et al. Generation of Induced Pluripotent Stem Cells from Lymphoblastoid Cell Lines by Electroporation of Episomal Vectors. Int J Stem Cells. 2022;: pubmed publisher

Sukparangsi W, Thongphakdee A, Karoon S, Suban Na Ayuthaya N, Hengkhunthod I, Prakongkaew R, et al. Establishment of fishing cat cell biobanking for sustainable conservation. Front Vet Sci. 2022;9:989670 pubmed publisher

Mencke P, Boussaad I, Onal G, Kievit A, Boon A, Mandemakers W, et al. Generation and characterization of a genetic Parkinson's disease-patient derived iPSC line DJ-1-delP (LCSBi008-A). Stem Cell Res. 2022;62:102792 pubmed publisher

de Rus Jacquet A, Tancredi J, Lemire A, DeSantis M, Li W, O Shea E. The LRRK2 G2019S mutation alters astrocyte-to-neuron communication via extracellular vesicles and induces neuron atrophy in a human iPSC-derived model of Parkinson's disease. elife. 2021;10: pubmed publisher

Beekhuis Hoekstra S, Watanabe K, Werme J, de Leeuw C, Paliukhovich I, Li K, et al. Systematic assessment of variability in the proteome of iPSC derivatives. Stem Cell Res. 2021;56:102512 pubmed publisher

Vermeer M, Bolling M, Bliley J, Arevalo Gomez K, Pavez Giani M, Kramer D, et al. Gain-of-function mutation in ubiquitin-ligase KLHL24 causes desmin degradation and dilatation in hiPSC-derived engineered heart tissues. J Clin Invest. 2021;: pubmed publisher

Bliley J, Vermeer M, Duffy R, Batalov I, Kramer D, Tashman J, et al. Dynamic loading of human engineered heart tissue enhances contractile function and drives a desmosome-linked disease phenotype. Sci Transl Med. 2021;13: pubmed publisher

Mengel D, Traschütz A, Reich S, Leyva Gutiérrez A, Bender F, Hauser S, et al. A de novo STUB1 variant associated with an early adult-onset multisystemic ataxia phenotype. J Neurol. 2021;: pubmed publisher

Liu R, Qian K, Xiao Y, Jiang W. Generation of two induced pluripotent stem cell lines from blood cells of a prostate cancer patient carrying germline mutation in CHEK2. Stem Cell Res. 2021;53:102299 pubmed publisher

Inzunza J, Arias Fuenzalida J, Segura Aguilar J, Nalvarte I, Varshney M. Generation of nonviral integration-free human iPS cell line KISCOi001-A from normal human fibroblasts, under defined xeno-free and feeder-free conditions. Stem Cell Res. 2021;51:102193 pubmed publisher

Zanin M, Santos B, Antony P, Berenguer Escuder C, Larsen S, Hanss Z, et al. Mitochondria interaction networks show altered topological patterns in Parkinson's disease. NPJ Syst Biol Appl. 2020;6:38 pubmed publisher

Xia S, Wang X, Yue P, Li Y, Zhang D. Establishment of induced pluripotent stem cell lines from a family of an ARVC patient receiving heart transplantation in infant age carrying compound heterozygous mutations in DSP gene. Stem Cell Res. 2020;48:101977 pubmed publisher

Klofas L, Short B, Snow J, Sinnaeve J, Rushing G, Westlake G, et al. DEPDC5 haploinsufficiency drives increased mTORC1 signaling and abnormal morphology in human iPSC-derived cortical neurons. Neurobiol Dis. 2020;143:104975 pubmed publisher

Varderidou Minasian S, Hinz L, Hagemans D, Posthuma D, Altelaar M, Heine V. Quantitative proteomic analysis of Rett iPSC-derived neuronal progenitors. Mol Autism. 2020;11:38 pubmed publisher

Zhou Y, Jing Y, Mao S, Liu J, Cui Z, Wang Y, et al. Establishment of induced pluripotent stem cell line CSUASOi004-A by reprogramming peripheral blood mononuclear cells of a PRPF6-related dominant retinitis pigmentosa patient. Stem Cell Res. 2020;45:101793 pubmed publisher

Zhou Y, Ding C, Xia S, Jing Y, Mao S, Liu J, et al. Establishment of induced pluripotent stem cell line CSUASOi003- A from an autosomal recessive retinitis pigmentosa patient carrying compound heterozygous mutations in CRB1 gene. Stem Cell Res. 2020;44:101742 pubmed publisher

Mao S, Ding C, Zhou Y, Jing Y, Chen J, Guo Y, et al. Establishment of a human induced pluripotent stem cell line (CSUASOi005-A), from peripheral blood mononuclear cells of a patient with X-linked juvenile retinoschisis carrying a novel mutation in RS1 gene. Stem Cell Res. 2020;43:101718 pubmed publisher

Bouma M, Freund C, Ijzerman A, Boomsma D, Mummery C, Raymond K. Lymphoblast-derived hiPS cell lines generated from four individuals of a family of genetically unrelated parents and their female monozygotic twins. Stem Cell Res. 2019;41:101654 pubmed publisher

Low J, Li P, Chew E, Zhou B, Suzuki K, Zhang T, et al. Generation of Human PSC-Derived Kidney Organoids with Patterned Nephron Segments and a De Novo Vascular Network. Cell Stem Cell. 2019;25:373-387.e9 pubmed publisher

Nagel M, Reichbauer J, Böhringer J, Schelling Y, Krageloh Mann I, Schule R, et al. Generation of two iPSC lines derived from two unrelated patients with Gaucher disease. Stem Cell Res. 2019;35:101336 pubmed publisher

Hinz L, Hoekstra S, Watanabe K, Posthuma D, Heine V. Generation of Isogenic Controls for In Vitro Disease Modelling of X-Chromosomal Disorders. Stem Cell Rev. 2019;15:276-285 pubmed publisher

Yang Y, Liu B, Xu J, Wang J, Wu J, Shi C, et al. Derivation of Pluripotent Stem Cells with In Vivo Embryonic and Extraembryonic Potency. Cell. 2017;169:243-257.e25 pubmed publisher

Hauser S, Höflinger P, Theurer Y, Rattay T, Schols L. Generation of induced pluripotent stem cells (iPSCs) from a hereditary spastic paraplegia patient carrying a homozygous Y275X mutation in CYP7B1 (SPG5). Stem Cell Res. 2016;17:437-440 pubmed publisher

Höflinger P, Hauser S, Theurer Y, Weißenberger S, Wilke C, Schols L. Induced pluripotent stem cells (iPSCs) derived from cerebrotendinous xanthomatosis (CTX) patient's fibroblasts carrying a R395S mutation. Stem Cell Res. 2016;17:433-436 pubmed publisher

Hauser S, Schuster S, Theurer Y, Synofzik M, Schols L. Generation of optic atrophy 1 patient-derived induced pluripotent stem cells (iPS-OPA1-BEHR) for disease modeling of complex optic atrophy syndromes (Behr syndrome). Stem Cell Res. 2016;17:426-429 pubmed publisher

Höflinger P, Theurer Y, Schule R, Schols L, Hauser S. Generation of induced pluripotent stem cells (iPSCs) from a hereditary spastic paraplegia patient carrying a homozygous R486C mutation in CYP7B1 (SPG5). Stem Cell Res. 2016;17:422-425 pubmed publisher

Nimsanor N, Jørring I, Rasmussen M, Clausen C, Mau Holzmann U, Kitiyanant N, et al. Induced pluripotent stem cells (iPSCs) derived from a symptomatic carrier of a S305I mutation in the microtubule-associated protein tau (MAPT)-gene causing frontotemporal dementia. Stem Cell Res. 2016;17:564-567 pubmed publisher

Nimsanor N, Jørring I, Rasmussen M, Clausen C, Mau Holzmann U, Bus C, et al. Generation of induced pluripotent stem cells derived from a 77-year-old healthy woman as control for age related diseases. Stem Cell Res. 2016;17:550-552 pubmed publisher

Hauser S, Erzler M, Theurer Y, Schuster S, Schule R, Schols L. Establishment of SPAST mutant induced pluripotent stem cells (iPSCs) from a hereditary spastic paraplegia (HSP) patient. Stem Cell Res. 2016;17:485-488 pubmed publisher

Li T, Pires C, Nielsen T, Waldemar G, Hjermind L, Nielsen J, et al. Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying a M146I mutation in PSEN1. Stem Cell Res. 2016;16:334-7 pubmed publisher

Li T, Pires C, Nielsen T, Waldemar G, Hjermind L, Nielsen J, et al. Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying an A79V mutation in PSEN1. Stem Cell Res. 2016;16:229-32 pubmed publisher

Marthaler A, Schmid B, Tubsuwan A, Poulsen U, Hyttel P, Nielsen T, et al. Generation of spinocerebellar ataxia type 2 patient-derived iPSC line H196. Stem Cell Res. 2016;16:199-201 pubmed publisher

Marthaler A, Schmid B, Tubsuwan A, Poulsen U, Hyttel P, Nielsen T, et al. Generation of spinocerebellar ataxia type 2 patient-derived iPSC line H266. Stem Cell Res. 2016;16:166-9 pubmed publisher

Marthaler A, Tubsuwan A, Schmid B, Poulsen U, Hyttel P, Nielsen J, et al. Generation of spinocerebellar ataxia type 2 patient-derived iPSC line H271. Stem Cell Res. 2016;16:159-61 pubmed publisher

Rasmussen M, Hjermind L, Hasholt L, Waldemar G, Nielsen J, Clausen C, et al. Induced pluripotent stem cells (iPSCs) derived from a pre-symptomatic carrier of a R406W mutation in microtubule-associated protein tau (MAPT) causing frontotemporal dementia. Stem Cell Res. 2016;16:105-9 pubmed publisher

Rasmussen M, Hjermind L, Hasholt L, Waldemar G, Nielsen J, Clausen C, et al. Induced pluripotent stem cells (iPSCs) derived from a patient with frontotemporal dementia caused by a P301L mutation in microtubule-associated protein tau (MAPT). Stem Cell Res. 2016;16:70-4 pubmed publisher

Rasmussen M, Holst B, Tümer Z, Johnsen M, Zhou S, Stummann T, et al. Transient p53 suppression increases reprogramming of human fibroblasts without affecting apoptosis and DNA damage. Stem Cell Reports. 2014;3:404-13 pubmed publisher

Okita K, Matsumura Y, Sato Y, Okada A, Morizane A, Okamoto S, et al. A more efficient method to generate integration-free human iPS cells. Nat Methods. 2011;8:409-12 pubmed publisher